Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Melinda Telli
Condition: Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer
NCT02401347
Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.